D. Janousek

发表

Prognostic relevance of dic(9;20)(p11;q13) in childhood B‐cell precursor acute lymphoblastic leukaemia treated with Berlin‐Frankfurt‐Münster (BFM) protocols containing an intensive induction and post‐induction consolidation therapy

A. Teigler‐Schlegel, M. König, J. Harbott, 2010, British journal of haematology.

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

O. Delattre, G. Tonini, H. Caron, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

M. König, J. Harbott, O. Haas, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

O. Haas, M. Schrappe, A. Attarbaschi, 2010, British journal of haematology.

Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

O. Haas, M. Schrappe, A. Attarbaschi, 2010, British Journal of Haematology.

Age-dependency of the prognostic impact of tumor genomics in localized resectable MYCN non-amplified neuroblastomas Report from the SIOPEN Biology Group on the LNESG Trials

O. Delattre, G. Tonini, B. Bernardi, 2018 .